Showing 22,152 results

Filters Content type: Editors' picks
Changing treatment

‘The Devil You Know’: Many People Over 50 Are Taking Outdated ART, Despite Side Effects

Editor's pick
TheBodyPro
27 April 2022
Bad science & bogus treatments

WHO Warns of Dangers of Health Misinformation Across Social Media Following Elon Musk’s $44 bn Twitter Acquisition 

Editor's pick
Health Policy Watch
27 April 2022
People & personal stories

Transgender and Openly HIV-Positive 'Transparent' Star Alexandra Billings Discusses Her New Memoir

Editor's pick
TheBody
27 April 2022
Pharmaceutical industry

GSK's ViiV, Pfizer and Roche's Genentech earn top ranks among patient advocacy groups

Editor's pick
FiercePharma
27 April 2022
Epidemiology & behaviour

San Francisco supervisors lift gay bathhouse prohibitions

Editor's pick
Bay Area Reporter
27 April 2022
Access to healthcare

Tigray's health system 'totally collapsed', say health workers

Editor's pick
The New Humanitarian
26 April 2022
Pharmaceutical industry

Buckle up! The ‘Staley vs Gilead’ lawsuit could cost Big Pharma billions

Editor's pick
My Fabulous Disease
26 April 2022
Activism & civil society

Aid Workers in Ukraine Fight to Deliver Supplies Despite Lives Lost to Russian Shelling

Editor's pick
The New York Times
26 April 2022
Access to healthcare

PEPFAR Investing US $13 Million to Reach Ukrainians in Need with Life-Saving HIV Treatment

Editor's pick
U.S. Department of State
26 April 2022
Clinical trials

HIV Cure Research Lacks Diversity From the Earliest Stages, Scientists Warn

Editor's pick
TheBodyPro
26 April 2022
The biology of HIV transmission

HIV Transmitted Through Heterosexual Sex May Initially Be ‘Fitter,’ but Likely Has No Effect on Prevention and Treatment

Editor's pick
TheBodyPro
26 April 2022
Harm reduction

Sustaining HIV services for people who use drugs in Odesa

Editor's pick
UNAIDS
25 April 2022
Neurological & cognitive problems

Computerized Cognitive Training May Help HIV-Associated Neurocognitive Disorder

Editor's pick
Infectious Disease Advisor
25 April 2022
Health problems & ageing

ACTG launches A5383, clinical trial evaluating potential immunologic benefits of treating asymptomatic CMV in people living with HIV

Editor's pick
EurekAlert
25 April 2022
Opportunistic infections

In-depth: Critical medicine priced out of reach for people with cryptococcal meningitis

Editor's pick
Spotlight
25 April 2022
Harm reduction

New US Drug Control Strategy Takes Some Positive Steps But Can Go Much Further

Editor's pick
Cato Institute
22 April 2022
PrEP programmes & uptake

US: Black Women Prefer HIV Prevention Shots, But Cost is a Factor

Editor's pick
POZ
22 April 2022
The search for a cure

Antibody therapy controls HIV for months in new clinical trial

Editor's pick
The Rockerfeller University
22 April 2022
Pharmaceutical industry

Gilead wins court order against fraudsters targeting HIV programme

Editor's pick
Pharmaphorum
21 April 2022
Global health targets

‘Unique on a global scale’: New South Wales nears elimination of HIV as cases fall to record lows

Editor's pick
Sydney Morning Herald
21 April 2022
HIV in the arts & media

'PrEP Play, or Blue Parachute Strong' - strong medicine needs more regimen

Editor's pick
Bay Area Reporter
21 April 2022
Opportunistic infections

New guidelines from WHO recommend a simpler, safer treatment for cryptococcal disease in people living with HIV

Editor's pick
World Health Organization
21 April 2022
Migrants, refugees & displaced people

Welcoming Ukrainian refugees in Germany: big test for all

Editor's pick
UNAIDS
21 April 2022
TB diagnosis

Tuberculosis patients in Ukraine at risk, some refugee groups to be tested

Editor's pick
EURACTIV
19 April 2022